使用多甲基甲酸膜进行在线血清过后稀释去除α1-微球蛋白:一项开放式单臂研究
Shiori Yoshida1, Suguru Yamamoto1, Daisuke Miyauchi1
1Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Blood purification
|November 8, 2023
概括
用聚甲基甲酸盐 (PMMA) 膜进行在线血液过后稀释,在末期脏病 (ESKD) 患者中有效地去除α1-microglobulin (α1-m) 和β2-microglobulin (β2-m). 这种方法可以改善中高分子量蛋白质的去除,而不会增加专辑蛋白泄漏.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物材料科学 生物材料科学
- 临床医学 临床医学
背景情况:
- 使用高流量膜的在线血液过 (OL-HDF) 改善了低和中分子量蛋白质的去除,但患者在末期病 (ESKD) 中的结果仍然不理想.
- 阿尔法1-微球蛋白 (α1-m) 是一种中高分子量蛋白质,可能会导致透析相关的并发症和死亡率,但其去除不足以使用使用聚硫 (PS) 膜的当前OL-HDF.
- 聚甲基甲酸盐 (PMMA) 膜具有对中高分子量蛋白质的吸附能力.
研究的目的:
- 评估OL-HDF与PMMA膜 (Post-PMMA) 稀释后在去除中高分子量蛋白质,特别是α1-m和β2-微球蛋白 (β2-m) 的有效性.
- 为了比较Post-PMMA的蛋白质去除效率与使用PS膜 (Pre-PS) 的预稀释OL-HDF.
主要方法:
- 这是一项开放式单臂研究,涉及7名ESKD患者,他们之前接受过Pre-PS治疗.
- 患者接受了后PMMA,其替代体积为30毫升/分钟 (低流量) 和50毫升/分钟 (高流量).
- 60分钟和240分钟测量了α1-m,β2-m,小分子,炎症性细胞因子和专蛋白的清除和除去率.
主要成果:
- 与前PS相比,PMMA后的α1-m的去除率显著更高 (高流量:17.7 ± 5.9%;低流量:15.0 ± 5.6%与前PS相比:4.1 ± 5.5%).
- 在PMMA后,β2-m的吸附清除增加了.
- 在后PMMA和前PS之间,白蛋白泄漏是可比的,这表明风险没有增加.
结论:
- 带有PMMA膜的后PMMAOL-HDF在去除α1-m方面比前PSOL-HDF更有效.
- PMMA膜有效吸附β2-m,突出其在去除中高分子量蛋白质方面的实用性.
- 后PMMA为ESKD患者提供了一种有前途的方法,特别是那些营养状况不佳的患者,因为它可以有效地去除蛋白质,而不会造成显著的白蛋白损失.
相关概念视频
Dialysis
703
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
703
Hemodialysis I: Introduction
36
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
36
Hemodialysis II: Procedure and Complications
26
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
26
Continuous Renal Replacement Therapy
38
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
38


